What have the Framingham cohorts taught us about hyperuricemia and gout?

ISSN： 1758-4272

Source： International Journal of Clinical Rheumatology, Vol.8, Iss.2, 2013-04, pp. : 149-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Febuxostat, a novel drug for the treatment of hyperuricemia of gout

By Perez-Ruiz Fernando Dalbeth Nicola Schlesinger Naomi

Future Rheumatology, Vol. 3, Iss. 5, 2008-10 ,pp. : 421-427

Future Medicine

Access to resources Recommend Favorite

Febuxostat: a safe and effective therapy for hyperuricemia and gout

By Jordan Natasha McCarthy Geraldine M

Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. : 303-309

Future Medicine

Access to resources Recommend Favorite

Endoscopic Gastritis: What Does It Mean?

By Lee Sun-Young

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2209-2211

Springer Publishing Company

Access to resources Recommend Favorite

Robotic versus laparoscopic adrenalectomy: what is the best?

By Brunaud Laurent

Expert Review of Endocrinology and Metabolism, Vol. 7, Iss. 6, 2012-11 ,pp. : 625-627

Informa Healthcare

Access to resources Recommend Favorite

Genomic science: what are the implications for personalized diabetes care?

By Kant Ravi Silver Kristi

Diabetes Management, Vol. 3, Iss. 3, 2013-05 ,pp. : 225-234

Future Medicine

Access to resources Recommend Favorite